A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials

Overview

Journal J Diabetes Sci Technol

Specialty Endocrinology

Date 2023 Aug 18

PMID 37592726

Authors

Elias K Spanakis

Curtiss B Cook

Kristen Kulasa

Joseph A Aloi

Lia Bally

Georgia Davis

Kathleen M Dungan

Rodolfo J Galindo

Carlos E Mendez

Francisco J Pasquel

Viral N Shah

Guillermo E Umpierrez

Rachel E Aaron

Tiffany Tian

Andrea M Yeung

Jingtong Huang

David C Klonoff

Affiliations

Soon will be listed here.

Abstract

Diabetes Technology Society organized an expert consensus panel to develop metrics for research in the use of continuous glucose monitors (CGMs) in a hospital setting. The experts met virtually in small groups both before and after an April 13, 2023 virtual meeting of the entire panel. The goal of the panel was to develop consensus definitions in anticipation of greater use of CGMs in hospital settings in the future. Establishment of consensus definitions of inpatient analytical metrics will be easier to compare outcomes between studies. Panelists defined terms related to 10 dimensions of measurements related to the use of CGMs including (1) hospital hypoglycemia, (2) hospital hyperglycemia, (3) hospital time in range, (4) hospital glycemic variability, (5) hospital glycemia risk index, (6) accuracy of CGM devices and reference methods for CGMs in the hospital, (7) meaningful time blocks for hospital glycemic goals, (8) hospital CGM data sufficiency, (9) using CGM data for insulin dosing, and (10) miscellaneous factors. The panelists voted on 51 proposed recommendations. Based on the panel vote, 51 recommendations were classified as either strong (43) or mild (8). Additional research is needed on CGM performance in the hospital. This consensus report is intended to support that type of research intended to improve outcomes for hospitalized people with diabetes.

Citing Articles

Continuous Glucose Monitoring in Hospitalized Adults With Diabetic Ketoacidosis: A Prospective Open-Label Pilot Study.

Bogun M, Wang C, Kurlansky P, Bedeir N, Umpierrez G J Diabetes Sci Technol. 2025; :19322968251316887.

PMID: 39907056 PMC: 11800229. DOI: 10.1177/19322968251316887.

Accuracy of continuous glucose monitoring systems in intensive care unit patients: a scoping review.

Nielsen C, Grigonyte-Daraskeviciene M, Olsen M, Moller M, Norgaard K, Perner A Intensive Care Med. 2024; 50(12):2005-2018.

PMID: 39417874 DOI: 10.1007/s00134-024-07663-6.

Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin.

Lee M, Seav S, Ongwela L, Lee J, Aubyrn R, Cao F Diabetes Care. 2024; 47(10):1838-1845.

PMID: 39140891 PMC: 11417271. DOI: 10.2337/dc24-0626.

Real-time continuous glucose monitoring-guided glucose management in inpatients with diabetes receiving short-term continuous subcutaneous insulin infusion: a randomized clinical trial.

Wang Y, Lu J, Wang M, Ni J, Yu J, Wang S Lancet Reg Health West Pac. 2024; 48:101067.

PMID: 39119238 PMC: 11305887. DOI: 10.1016/j.lanwpc.2024.101067.

Hyperglycemic Crises in Adults With Diabetes: A Consensus Report.

Umpierrez G, Davis G, ElSayed N, Fadini G, Galindo R, Hirsch I Diabetes Care. 2024; 47(8):1257-1275.

PMID: 39052901 PMC: 11272983. DOI: 10.2337/dci24-0032.

References

Agarwal S, Mathew J, Davis G, Shephardson A, Levine A, Louard R . Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic. Diabetes Care. 2020; 44(3):847-849. PMC: 7896255. DOI: 10.2337/dc20-2219. View

Hirsch I . Glycemic variability: it's not just about A1C anymore!. Diabetes Technol Ther. 2005; 7(5):780-3. DOI: 10.1089/dia.2005.7.780. View

Suh S, Kim J . Glycemic Variability: How Do We Measure It and Why Is It Important?. Diabetes Metab J. 2015; 39(4):273-82. PMC: 4543190. DOI: 10.4093/dmj.2015.39.4.273. View

Golden S, Kao W, Brancati F . Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999; 22(9):1408-14. DOI: 10.2337/diacare.22.9.1408. View

Spanakis E, Umpierrez G, Siddiqui T, Zhan M, Snitker S, Fink J . Association of Glucose Concentrations at Hospital Discharge With Readmissions and Mortality: A Nationwide Cohort Study. J Clin Endocrinol Metab. 2019; 104(9):3679-3691. PMC: 6642668. DOI: 10.1210/jc.2018-02575. View

Roldan V, Urtecho M, Nayfeh T, Firwana M, Muthusamy K, Hasan B . A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia. J Clin Endocrinol Metab. 2022; 108(3):592-603. DOI: 10.1210/clinem/dgac601. View

Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M . Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002; 106(16):2067-72. DOI: 10.1161/01.cir.0000034509.14906.ae. View

Ekhlaspour L, Mondesir D, Lautsch N, Balliro C, Hillard M, Magyar K . Comparative Accuracy of 17 Point-of-Care Glucose Meters. J Diabetes Sci Technol. 2016; 11(3):558-566. PMC: 5505415. DOI: 10.1177/1932296816672237. View

Benhamou P, Adenis A, Tourki Y, Pou S, Madrolle S, Franc S . Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 System. J Diabetes Sci Technol. 2022; 18(2):372-379. PMC: 10973855. DOI: 10.1177/19322968221128565. View

10.

Shah V, Sakamoto C, Pyle L . Optimal Sampling Duration for Continuous Glucose Monitoring for the Estimation of Glycemia Risk Index. Diabetes Technol Ther. 2022; 25(2):140-142. DOI: 10.1089/dia.2022.0401. View

11.

Bally L, Thabit H, Hartnell S, Andereggen E, Ruan Y, Wilinska M . Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care. N Engl J Med. 2018; 379(6):547-556. DOI: 10.1056/NEJMoa1805233. View

12.

Stentz F, Umpierrez G, Cuervo R, Kitabchi A . Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004; 53(8):2079-86. DOI: 10.2337/diabetes.53.8.2079. View

13.

Moghissi E, Korytkowski M, DiNardo M, Einhorn D, Hellman R, Hirsch I . American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009; 32(6):1119-31. PMC: 2681039. DOI: 10.2337/dc09-9029. View

14.

Di J, Demanuele C, Kettermann A, Karahanoglu F, Cappelleri J, Potter A . Considerations to address missing data when deriving clinical trial endpoints from digital health technologies. Contemp Clin Trials. 2021; 113:106661. DOI: 10.1016/j.cct.2021.106661. View

15.

Holzinger U, Warszawska J, Kitzberger R, Wewalka M, Miehsler W, Herkner H . Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2009; 33(3):467-72. PMC: 2827490. DOI: 10.2337/dc09-1352. View

16.

Turchin A, Matheny M, Shubina M, Scanlon J, Greenwood B, Pendergrass M . Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009; 32(7):1153-7. PMC: 2699723. DOI: 10.2337/dc08-2127. View

17.

Davis G, Spanakis E, Migdal A, Singh L, Albury B, Urrutia M . Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients With Diabetes. Diabetes Care. 2021; 44(7):1641-1646. PMC: 8323182. DOI: 10.2337/dc20-2856. View

18.

Su G, Mi S, Tao H, Li Z, Yang H, Zheng H . Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care. 2013; 36(4):1026-32. PMC: 3609497. DOI: 10.2337/dc12-0925. View

19.

Beck R, Bergenstal R, Cheng P, Kollman C, Carlson A, Johnson M . The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c. J Diabetes Sci Technol. 2019; 13(4):614-626. PMC: 6610606. DOI: 10.1177/1932296818822496. View

20.

Satyarengga M, Siddiqui T, Spanakis E . Designing the Glucose Telemetry for Hospital Management: From Bedside to the Nursing Station. Curr Diab Rep. 2018; 18(10):87. DOI: 10.1007/s11892-018-1067-4. View